Azitra Competitors and Similar CompaniesClear all
Azitra's competitors and similar companies include Transition Bio, Trefoil Therapeutics and Vedanta Biosciences.
 Transition Bio Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis. |  Trefoil Therapeutics Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases. |  Vedanta Biosciences Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases. | ||
Founding Date | Founding Date 2014 | Founding Date 2020 | Founding Date 2014 | Founding Date 2010 |
Type | Type Public | Type Private | Type Private | Type Private |
Tags | ||||
Locations | Locations Branford, US HQ | Locations Cambridge, US HQ Cambridge, GB | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 10 | Employees 2915% decrease | Employees 138% increase | Employees 1381% increase |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round $ 50m (about 4 years ago) | Latest funding round $ 28m (almost 7 years ago) | Latest funding round $ 68m (almost 5 years ago) |
Total funding raised | Total funding raised $ 20.8m | Total funding raised $ 50m | Total funding raised $ 33.2m | Total funding raised $ 185.5m |
For sources of this data, please see the company profile
View Company Profiles
Transition Bio
HQ
Cambridge, US
Employees
29↓ 15% decrease
Transition Bio is a biotechnology company that provides technologies for biomolecular condensate analysis.
View companyTrefoil Therapeutics
HQ
San Diego, US
Employees
13↑ 8% increase
Trefoil Therapeutics is a biotechnology company focused on leveraging its engineered fibroblast growth factor-1 protein (eFGF-1) technology platform to develop regenerative pharmacologic treatments for corneal diseases.
View companyVedanta Biosciences
HQ
Cambridge, US
Employees
138↑ 1% increase
Vedanta Biosciences was founded by PureTech and a team of world renowned experts in immunology and microbiology. Vedanta Biosciences is developing a class of drugs that work by modulating the human microbiome, with an initial emphasis in autoimmune and inflammatory diseases.
View company